Macarena Hernández Jiménez
@makimhj
Followers
101
Following
849
Statuses
82
Neuroscience, Biomedicine, Pharmacology, Clinical Trials
Joined January 2022
RT @sanidadgob: 🧠 Celebramos la Jornada de Presentación de la Actualización 2024 de la Estrategia en Ictus. 🏥 Con 120.000 casos anuales en…
0
22
0
RT @Ricors_Ictus: Next week we are busy in #RICORSICTUS🧠 We gather at🏥@VHIR_ hosted by @lin_vhir for: - our 3rd Annual Congress, sharing t…
0
11
0
Very glad of participating in this excellent session together with Dr. María Hernández. A wonderful opportunity to learn about neuroinflammation and stroke directly from the experts in the field!
0
0
2
RT @FdeCastroS: Always good news to see a #PhD_thesis that you directed receiving the #CumLaude calification...! Congrats to brand-new doct…
0
4
0
Hoy la Doctora Fernández defendía su tesis doctoral tras 5 años de duro trabajo en los que he tenido la fortuna de participar con los mejores @FdeCastroS @AptaTargets Espero que hayas aprendido de mí tanto como yo de ti, Bea.
0
0
1
Un año más, comenzamos con ilusión el Título de Especialista en Intervenciones Asistidas con Caballos. Siempre hacia una mejora en la calidad de vida de los pacientes #IACs #rehabilitación #ictus @unicomplutense @VeterinariaUCM
0
1
1
Continuing exploring ApTOLL effects after a stroke!!
A new study shows the cerebroprotective effects of #ApTOLL on mice with #AcuteIschemicStroke: The study, published in "Pharmaceutics" (@MDPIpharma), was conducted by researchers at aptaTargets (Dr. Macarena Hernández) and @IISLaFe (Dr. Juan Salom).
0
4
10
RT @AptaTargets: Preclinical studies validate the potential of #ApTOLL developed by aptaTargets to reduce inflammation and regenerate myeli…
0
4
0
RT @AptaTargets: Our CSO Macarena Hernández (@makimhj) will speak at the 10th European #Stroke Conference next May 15 in Basel. Join us t…
0
3
0
RT @AptaTargets: In San Francisco for the @jpmorgan Healthcare Conference week! #JPM24 #ApTOLL #DrugDevelopment #neuroprotection #AcuteIsc…
0
3
0
RT @NEJM: Original Article: Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease (GRADUATE I and II phase 3 trials) https://t.co…
0
14
0
RT @ScienceMagazine: A new Review in @ScienceTM looks at the complex connections between astrocytes and other types of cells in the nervous…
0
354
0
RT @AptaTargets: ¿Quieres conocer nuevas terapias para el #ictus 🧠? No puedes perderte esta jornada divulgativa de @madrimasd y IRYCIS en p…
0
6
0
RT @NatRevNeurol: New online! Molecular biomarkers for vascular cognitive impairment and dementia
0
98
0